PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules

被引：0
|
作者：
Shibo Qi
Susan Hoppmann
Yingding Xu
Zhen Cheng
机构：
[1] Tianjin Polytechnic University,School of Environmental and Chemical Engineering
[2] Stanford University,Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio
来源：
Molecular Imaging and Biology | 2019年 / 21卷
关键词：
PET; Affibody; HER2; Cu-64; Tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [31] The diagnostic value of 68Ga-NOTA-MAL-Cys-MZHER2:342 PET/CT imaging for HER2-positive lung adenocarcinoma
    Li, Shu
    Wang, Ke
    Zhu, Xue
    Pan, Donghui
    Wang, Ling
    Guo, Xu
    Gao, Xiaomin
    Luo, Qing
    Wang, Xun
    FRONTIERS IN MEDICINE, 2024, 11
  • [32] Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules
    Kramer-Marek, Gabriela
    Kiesewetter, Dale O.
    Capala, Jacek
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (07) : 1131 - 1139
  • [33] On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
    Orlova, Anna
    Wullberg, Helena
    Stone-Elander, Sharon
    Tolmachev, Vladimir
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) : 417 - 425
  • [34] In Vivo Assessment of HER2 Receptor Density in HER2-positive Tumors by Near-infrared Imaging, Using Repeated Injections of the Fluorescent Probe
    Ardeshirpour, Yasaman
    Hassan, Moinuddin
    Zielinski, Rafal
    Horton, Jason A.
    Capala, Jacek
    Gandjbakhche, Amir H.
    Chernomordik, Victor
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2014, 13 (05) : 427 - 434
  • [35] Comparison of an Affibody-based Molecular Probe and 18F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT
    Guo, Xiaoyi
    Zhou, Nina
    Liu, Jiayue
    Ding, Jin
    Liu, Teti
    Song, Guohong
    Zhu, Hua
    Yang, Zhi
    RADIOLOGY, 2024, 311 (03)
  • [36] PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab
    Luo, Haiming
    England, Christopher G.
    Graves, Stephen A.
    Sun, Haiyan
    Liu, Glenn
    Nickles, Robert I.
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (02) : 285 - 290
  • [37] Production of 64 Cu-labeled monobody for imaging of human EphA2-expressing tumors
    Pyo, Ayoung
    You, Sung-Hwan
    Kim, Hyeon Sik
    Kim, Jung Young
    Min, Jung-Joon
    Kim, Dong-Yeon
    Hong, Yeongjin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (14)
  • [38] Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy
    Eissler, Nina
    Altena, Renske
    Alhuseinalkhudhur, Ali
    Bragina, Olga
    Feldwisch, Joachim
    Wuerth, Guido
    Loftenius, Annika
    Brun, Nikolai
    Axelsson, Rimma
    Tolmachev, Vladimir
    Sorensen, Jens
    Frejd, Fredrik Y.
    BIOMEDICINES, 2024, 12 (05)
  • [39] HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
    Rinne, Sara S.
    Leitao, Charles Dahlsson
    Abouzayed, Ayman
    Vorobyeva, Anzhelika
    Tolmachev, Vladimir
    Stahl, Stefan
    Lofblom, John
    Orlova, Anna
    CANCERS, 2021, 13 (19)
  • [40] Molecular Imaging of Atherosclerotic Plaque with 64Cu-Labeled Natriuretic Peptide and PET
    Liu, Yongjian
    Abendschein, Dana
    Woodard, Geoffrey E.
    Rossin, Raffaella
    McCommis, Kyle
    Zheng, Jie
    Welch, Michael J.
    Woodard, Pamela K.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (01) : 85 - 91
12345